Hansoh Pharma IPO: Valuation Reasonable for the Trade-Offs

725 Views03 Jun 2019 04:21

Hansoh Pharmaceutical (3692 HK) claims to be one of the few R&D driven Chinese pharmaceutical companies. It announced its IPO price range of...

SUMMARY

(Sign Up to Access)

Try Now

Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

SMARTKARMA PREVIEW PASS

By signing up, you agree to our
Terms of Use and Privacy Policy.

Already have an account? Sign In Now

Full Insight

(Paid Plans Only, 4-minute read)

Discussions

(Paid Plans Only)

Top 5%

IPOs and Catalysts/Events

Global Equity Research Ltd

Information TechnologyEquitiesEquity Capital MarketsEvent-Driven

Price Chart(Sign Up to Access)

Insight Stream